Malignant rectal GIST managed with chemotherapy (Imatinib Mesylate): A case report and a comprehensive review

Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors involving the gastrointestinal tract, arising from the interstitial cells of Cajal. GIST comprises about 1% of all GI tumors. Rectal GISTs are rare and comprise of approximately 5% of all GISTs and only 0.1% of rectal tum...

Full description

Bibliographic Details
Main Authors: Amrit Bhusal, Suraj KC, Tek Nath Yogi, Rakesh Kumar Gupta, Abhijeet Kumar, Bhawani Khanal, Shailendra Katwal, Durga Neupane, Samikshya Lamichhane, Ranjan Bhagat
Format: Article
Language:English
Published: Elsevier 2024-04-01
Series:Radiology Case Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1930043323009597
_version_ 1827339755760648192
author Amrit Bhusal
Suraj KC
Tek Nath Yogi
Rakesh Kumar Gupta
Abhijeet Kumar
Bhawani Khanal
Shailendra Katwal
Durga Neupane
Samikshya Lamichhane
Ranjan Bhagat
author_facet Amrit Bhusal
Suraj KC
Tek Nath Yogi
Rakesh Kumar Gupta
Abhijeet Kumar
Bhawani Khanal
Shailendra Katwal
Durga Neupane
Samikshya Lamichhane
Ranjan Bhagat
author_sort Amrit Bhusal
collection DOAJ
description Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors involving the gastrointestinal tract, arising from the interstitial cells of Cajal. GIST comprises about 1% of all GI tumors. Rectal GISTs are rare and comprise of approximately 5% of all GISTs and only 0.1% of rectal tumors are found to be GISTs. Rectal GISTs may be diagnosed incidentally or present with symptoms, including defecation problems, bleeding, and/or pain. We report a case of a 46-year-old male with rectal GIST metastasized to the liver and bilateral lung parenchyma managed by Imatinib Mesylate (IM) regimen. Rectal GIST although being rare, must be considered as a differential diagnosis in a patient presenting with defecatory problems with bleeding.
first_indexed 2024-03-07T20:05:20Z
format Article
id doaj.art-aae39a4e59d94b219d976acc5f6d9efc
institution Directory Open Access Journal
issn 1930-0433
language English
last_indexed 2024-03-07T20:05:20Z
publishDate 2024-04-01
publisher Elsevier
record_format Article
series Radiology Case Reports
spelling doaj.art-aae39a4e59d94b219d976acc5f6d9efc2024-02-28T05:13:00ZengElsevierRadiology Case Reports1930-04332024-04-0119414241431Malignant rectal GIST managed with chemotherapy (Imatinib Mesylate): A case report and a comprehensive reviewAmrit Bhusal0Suraj KC1Tek Nath Yogi2Rakesh Kumar Gupta3Abhijeet Kumar4Bhawani Khanal5Shailendra Katwal6Durga Neupane7Samikshya Lamichhane8Ranjan Bhagat9Department of Radio-diagnostics and Imaging, BP Koirala Institute of Health Sciences (BPKIHS), Dharan, Sunsari, Nepal; Corresponding author.Department of General Surgery, BP Koirala Institute of Health Sciences (BPKIHS), Dharan, Sunsari, NepalBP Koirala Institute of Health Sciences (BPKIHS), Dharan, Sunsari, NepalDepartment of General Surgery, BP Koirala Institute of Health Sciences (BPKIHS), Dharan, Sunsari, NepalDepartment of General Surgery, BP Koirala Institute of Health Sciences (BPKIHS), Dharan, Sunsari, NepalDepartment of General Surgery, BP Koirala Institute of Health Sciences (BPKIHS), Dharan, Sunsari, NepalDepartment of Radiology, Dadeldhura Subregional Hospital, Dadeldhura, NepalDepartment of General Surgery, BP Koirala Institute of Health Sciences (BPKIHS), Dharan, Sunsari, NepalDepartment of Radio-diagnostics and Imaging, BP Koirala Institute of Health Sciences (BPKIHS), Dharan, Sunsari, NepalDepartment of General Surgery, BP Koirala Institute of Health Sciences (BPKIHS), Dharan, Sunsari, NepalGastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors involving the gastrointestinal tract, arising from the interstitial cells of Cajal. GIST comprises about 1% of all GI tumors. Rectal GISTs are rare and comprise of approximately 5% of all GISTs and only 0.1% of rectal tumors are found to be GISTs. Rectal GISTs may be diagnosed incidentally or present with symptoms, including defecation problems, bleeding, and/or pain. We report a case of a 46-year-old male with rectal GIST metastasized to the liver and bilateral lung parenchyma managed by Imatinib Mesylate (IM) regimen. Rectal GIST although being rare, must be considered as a differential diagnosis in a patient presenting with defecatory problems with bleeding.http://www.sciencedirect.com/science/article/pii/S1930043323009597Gastrointestinal stromal tumorsRectal tumorsMetastasisRareImatinib MesylateCase report
spellingShingle Amrit Bhusal
Suraj KC
Tek Nath Yogi
Rakesh Kumar Gupta
Abhijeet Kumar
Bhawani Khanal
Shailendra Katwal
Durga Neupane
Samikshya Lamichhane
Ranjan Bhagat
Malignant rectal GIST managed with chemotherapy (Imatinib Mesylate): A case report and a comprehensive review
Radiology Case Reports
Gastrointestinal stromal tumors
Rectal tumors
Metastasis
Rare
Imatinib Mesylate
Case report
title Malignant rectal GIST managed with chemotherapy (Imatinib Mesylate): A case report and a comprehensive review
title_full Malignant rectal GIST managed with chemotherapy (Imatinib Mesylate): A case report and a comprehensive review
title_fullStr Malignant rectal GIST managed with chemotherapy (Imatinib Mesylate): A case report and a comprehensive review
title_full_unstemmed Malignant rectal GIST managed with chemotherapy (Imatinib Mesylate): A case report and a comprehensive review
title_short Malignant rectal GIST managed with chemotherapy (Imatinib Mesylate): A case report and a comprehensive review
title_sort malignant rectal gist managed with chemotherapy imatinib mesylate a case report and a comprehensive review
topic Gastrointestinal stromal tumors
Rectal tumors
Metastasis
Rare
Imatinib Mesylate
Case report
url http://www.sciencedirect.com/science/article/pii/S1930043323009597
work_keys_str_mv AT amritbhusal malignantrectalgistmanagedwithchemotherapyimatinibmesylateacasereportandacomprehensivereview
AT surajkc malignantrectalgistmanagedwithchemotherapyimatinibmesylateacasereportandacomprehensivereview
AT teknathyogi malignantrectalgistmanagedwithchemotherapyimatinibmesylateacasereportandacomprehensivereview
AT rakeshkumargupta malignantrectalgistmanagedwithchemotherapyimatinibmesylateacasereportandacomprehensivereview
AT abhijeetkumar malignantrectalgistmanagedwithchemotherapyimatinibmesylateacasereportandacomprehensivereview
AT bhawanikhanal malignantrectalgistmanagedwithchemotherapyimatinibmesylateacasereportandacomprehensivereview
AT shailendrakatwal malignantrectalgistmanagedwithchemotherapyimatinibmesylateacasereportandacomprehensivereview
AT durganeupane malignantrectalgistmanagedwithchemotherapyimatinibmesylateacasereportandacomprehensivereview
AT samikshyalamichhane malignantrectalgistmanagedwithchemotherapyimatinibmesylateacasereportandacomprehensivereview
AT ranjanbhagat malignantrectalgistmanagedwithchemotherapyimatinibmesylateacasereportandacomprehensivereview